Status:
COMPLETED
A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®
Lead Sponsor:
Teva Neuroscience, Inc.
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.
Eligibility Criteria
Inclusion
- Male or Female, 18 years or older, with a diagnosis of RRMS
- Willing and able to complete all procedures and evaluations related to the study.
- Willing to provide Informed Consent
Exclusion
- Taking any other immunomodulatory therapy in conjunction with Copaxone®.
- Has a significant medical illness other than MS which may interfere with the assessment of endpoints or the subject's participation in the trial for the full duration of the study.
- Any situation which the investigator or nurse feels may interfere with participation in the study.
- Pregnant, or trying to become pregnant, or breast feeding during the study.
- Previously participated in this study.
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00239993
Start Date
August 1 2005
End Date
February 1 2006
Last Update
February 6 2017
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Fullerton Neurology & Headache Center
Fullerton, California, United States
2
Neurological Center of South Florida
Miami, Florida, United States
3
Springfield Neurology Associates
Springfield, Massachusetts, United States
4
Multiple Sclerosis Care Center
Brooklyn, New York, United States